United Labs Announces Lower Cost Insulin Drugs

United Laboratories International Holdings has received SFDA approval for three additional insulin products, bringing its total in this sector to five. The company will price its insulin products at a 10-15% discount to similar drugs already on the market. United Labs said it plans to invest up to 500 million RMB ($75.5 million) in its insulin business over the next few years. More details.... Stock Symbol: (HK: 3933)